Daniele Massera

📣Predictors of Left Ventricular Systolic Dysfunction on mavacamten in oHCM (n=180): 12% developed LVSD (echo EF <50%) over ~58 wks; LBBB/ventricular pacing (57% vs 22%), history of AF (48% vs 24%) and LGE burden associated with LVSD💡💉doi.org/10.1016/j.yjca… @JCFINT #HCM #cvHCM

Hypertrophic Cardiomyopathy, 3rd Edition, finally here! Tks to section editors @mmartinezheart @tikuowens @MasriAhmadMD & @MartinMaronMD and the 75 authors! @SpringerCardio @LindsayLuvDavis @LisaSalberg @DesaiMilindY @seiiwaiEPmd @AnkurKalraMD @SteveOmmen @scooperpr @purviparwani @hcmsociety @HcmPatient @danmassera @ChrisKramerMD @rooshaparikh @OKhaliqueMD @pkothapalliMD @Pooh_Velagapudi @rahatheart1 @SCAI @drsuneet @PrakashUpretiMD @DrJMarine

🚨Mark your calendars! Join us Sept 12 at NYU for our Hypertrophic Cardiomyopathy Symposium — cutting-edge science, expert panels, and the latest in diagnosis & treatment. Don’t miss it! #NYUCardiology Agenda highmarksce.com/nyumc/index.cf… highmarksce.com/nyumc/Planners…

Disopyramide appears safe and effective in treating symptomatic outflow obstruction in HCM over extended durations of time (≥5 years). #AHAJournals @danmassera @nyulangone @EthanRowin @LaheyHospital ahajrnls.org/4hC5AnC

Disopyramide for long-term treatment of obstructive #hcm? Check out our work looking at patients treated for ≥5 years at @nyulangone @LaheyHospital with 67% still on drug after ~7 years @EthanRowin @MartinMaronMD ahajournals.org/doi/full/10.11…

To everyone who joined us, THANK YOU. What a fantastic weekend. Enjoy our highlight reel featuring @jodieingles27 @danmassera @LisaSalberg @MKIttlesonMD @NtobekoNtusi @DrMarikoHarper1 @IacopoOlivotto #barrymaron @HishamAhamed3. (Full reel: hcmsummit.org.) #hcmsummit8

🍝Eating before resting and 🏃stress echo unmasked left ventricular outflow obstruction ≥50 mmHg in 35% of #HCM patients believed to have no significant obstruction. Check out our new data in @JournalASEcho #CardioTwitter #Echofirst @nyulangone onlinejase.com/article/S0894-…

@argulian Apical ballooning in ~1% of patients with known HCM: tinyurl.com/yc8w4be9 [also ~1% of patients in CMI trials] Features of obstructive HCM in unselected patients with Takotsubo syndrome: shorturl.at/o6YrC Shock due to LVOTO ⇨ apial ballooning: shorturl.at/vkQt3

@argulian In this case, LVOTO from SAM ⇨ apical ballooning in a patient with HCM and latent obstruction (note basal septal thickening and long anterior leaflet), not the other way around. Relief of obstruction ⇨ resolution of ballooning. shorturl.at/tZkCR

A patient with chest pain and normal coronaries, now hypotensive in the unit. Emergent echo is done. What is the diagnosis?

🚨Just 4 months away! Join us at the @hcmsummit in Boston (Oct 25-27). Hear from these 45 internationally renowned specialists at the definitive global scientific meeting on #hypertrophiccardiomyopathy. Tickets: hcmsummit.org. #cardiotwitter #cardioed #hcmsummit8 #hcm

IMPROVE-HCM: Targeting myocardial energetics with a novel mitotrope drug, #ninerafaxstat, was safe and improved exercise capacity and symptoms in nonobstructive #HCM. bit.ly/3wL3jok #JACC #cvHCM @BR_CMR @danmassera @SharonCresciMD @mmartinezheart @MartinMaronMD

Mitral Leaflet Shortening as an Ancillary Procedure in Obstructive Hypertrophic Cardiomyopathy - The Annals of Thoracic Surgery annalsthoracicsurgery.org/article/S0003-…

#ACC24 #JACC LBCT SimPub: IMPROVE-HCM - targeting myocardial energetics with novel mitotrope drug, #ninerafaxstat, was safe and improved exercise capacity and symptoms in nonobstructive HCM. bit.ly/3U7VxO2 #cvHCM @MartinMaronMD @BR_CMR @danmassera @SharonCresciMD

We are recruiting for an HCM attending cardiologist position at the NYU Langone Health Hypertrophic Cardiomyopathy Program. Information & apply here: jobs.nyulangone.org/job/17542344/h…

📢 Registration is officially OPEN for #HCMSummit8!📷 Join us in Boston 1 year from today (Oct 25-27, 2024). Register early & save $100 on tickets now through Dec 31. Visit hcmsummit.org for details & follow @hcmsummit for event updates. #hcm #hypertrophiccardiomyopathy

Congrats to this year's Critical Care Cardiology Symp course directors & faculty. An excellent line-up on advances in care for pts with acute CV issues! @danmassera @StephanieGolob @carlosalviar @ChrisBarnettMD @SamuelB316 @AnnGageMD @jameshorowitzmd @JasonKatzMD @CardsNYC

Registration open for the 3rd Critical Care Cardiology Symposium @nyulangone!! @BellevueHosp 🔥 Now expanded 1.5 days! 🔥@CardioNerds poster session! 🔥FIT Mentoring lunch 🔥 Crit care skills Sim session 🔥Endorsed by 5 ACC chapters! #critcarecards23 Nyulmc.org/critcarecardsc…

We are recruiting for an HCM attending cardiologist position at the NYU Langone Hypertrophic Cardiomyopathy Program. Information & apply here: careers.acc.org/job/hcm-attend…

#RCM - Vol. 24 No. 5 🪘Review Acute Left Ventricular Ballooning: Tools to Differentiate Hypertrophic Cardiomyopathy with Outflow Obstruction from Neurohumoral Takotsubo Syndrome 📒@ArushiSinghMD, @LouaiRazzouk, @danmassera, Mark V. Sherrid #HCM #TTS 📢 imrpress.com/journal/RCM/24…